| scholarly article | Q13442814 |
| P50 | author | Eric J. Chow | Q81355238 |
| Alan T. Remaley | Q91944002 | ||
| P2093 | author name string | Wassim Chemaitilly | |
| Minoo Battiwalla | |||
| Christine N Duncan | |||
| Michael A Pulsipher | |||
| Lee W Jones | |||
| Marcus Chen | |||
| Saro H Armenian | |||
| Nina Salooja | |||
| Alicia Rovo | |||
| P2860 | cites work | Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction | Q73690432 |
| Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer | Q73803736 | ||
| Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease | Q74372364 | ||
| Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997 | Q74460243 | ||
| Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation | Q75435483 | ||
| Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation | Q81461343 | ||
| Glucose metabolism and body composition in young adults treated with TBI during childhood | Q82852541 | ||
| Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents | Q83389066 | ||
| [Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain Study] | Q83630655 | ||
| Reduced beta-cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation | Q87604245 | ||
| Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement | Q22305291 | ||
| Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People | Q24633789 | ||
| Diagnosis and classification of diabetes mellitus | Q24654162 | ||
| 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q27010140 | ||
| Delivering care to long-term adult survivors of hematopoietic cell transplantation | Q27021501 | ||
| A Randomized Trial of Intensive versus Standard Blood-Pressure Control | Q27231406 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
| 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults | Q28239484 | ||
| Impaired fasting glucose and impaired glucose tolerance: implications for care | Q28290479 | ||
| Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens | Q28328148 | ||
| 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) | Q29617334 | ||
| Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study | Q33585366 | ||
| Late cardiovascular complications after hematopoietic cell transplantation | Q33605306 | ||
| AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology | Q33751628 | ||
| Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation | Q33926274 | ||
| Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). | Q33932870 | ||
| Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tr | Q33973013 | ||
| 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q34154032 | ||
| 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34351265 | ||
| Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor | Q34451605 | ||
| Body composition after bone marrow transplantation in childhood | Q34608891 | ||
| How I treat late effects in adults after allogeneic stem cell transplantation | Q34707208 | ||
| Modifiable risk factors and major cardiac events among adult survivors of childhood cancer | Q34977801 | ||
| Long-term survival and late deaths after allogeneic hematopoietic cell transplantation | Q35023409 | ||
| Insulin sensitizers may attenuate lean mass loss in older men with diabetes | Q35408045 | ||
| Endocrine deficit after fractionated total body irradiation | Q35448161 | ||
| National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage a | Q35549037 | ||
| Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation | Q35556074 | ||
| Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study | Q35597166 | ||
| Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study | Q40897879 | ||
| Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity | Q40949324 | ||
| Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association | Q41516673 | ||
| Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes. | Q41728635 | ||
| High-intensity strength training in nonagenarians. Effects on skeletal muscle | Q42154425 | ||
| Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation | Q43297417 | ||
| Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. | Q44110185 | ||
| Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1) | Q44693247 | ||
| Sarcopenic obesity is closely associated with metabolic syndrome | Q44844346 | ||
| Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver | Q45143164 | ||
| Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study | Q45143552 | ||
| Endothelial damage in long-term survivors of childhood cancer | Q45824243 | ||
| Hypercatabolic syndrome: molecular basis and effects of nutritional supplements with amino acids | Q46565780 | ||
| Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver | Q46744426 | ||
| Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation | Q46807792 | ||
| Final height and hormonal function after bone marrow transplantation in children | Q47324459 | ||
| Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis. | Q50951223 | ||
| Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. | Q51292585 | ||
| Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial. | Q51293272 | ||
| Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. | Q51380620 | ||
| Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. | Q51469352 | ||
| Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. | Q51492907 | ||
| Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. | Q51553088 | ||
| Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. | Q53537221 | ||
| Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients. | Q53677063 | ||
| Diagnosis and Classification of Diabetes Mellitus | Q56001184 | ||
| Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents | Q57414115 | ||
| TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation | Q58111846 | ||
| Impaired glucose tolerance after autologous bone marrow transplantation | Q68545469 | ||
| Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant | Q72377584 | ||
| ??? | Q28275865 | ||
| Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation | Q35604039 | ||
| Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study | Q35628840 | ||
| Physical Activity, Fitness, and Cardiometabolic Risk Factors in Adult Survivors of Childhood Cancer with a History of Hematopoietic Cell Transplantation | Q35738600 | ||
| Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation | Q35757247 | ||
| Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study | Q35847602 | ||
| Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study | Q35892403 | ||
| Midlife muscle strength and human longevity up to age 100 years: a 44-year prospective study among a decedent cohort | Q35916451 | ||
| Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia | Q36039024 | ||
| Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study | Q36141716 | ||
| Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study | Q36155132 | ||
| Muscular strength in male adolescents and premature death: cohort study of one million participants | Q36413345 | ||
| Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease | Q36440055 | ||
| Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study | Q36486430 | ||
| Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report | Q36783762 | ||
| Diabetes and altered glucose metabolism with aging | Q36875300 | ||
| Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study | Q36951682 | ||
| Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association | Q36953147 | ||
| Intramuscular lipid metabolism, insulin action, and obesity | Q37034193 | ||
| Late congestive heart failure after hematopoietic cell transplantation | Q37117167 | ||
| Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation. | Q37247613 | ||
| Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation | Q37460433 | ||
| Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events. | Q37593798 | ||
| Obesity in pediatric ALL survivors: a meta-analysis | Q37602512 | ||
| Cardiovascular disease in survivors of hematopoietic cell transplantation. | Q37624268 | ||
| Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer | Q37648395 | ||
| Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management | Q37741643 | ||
| Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation | Q37973498 | ||
| Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner. | Q38058445 | ||
| Cardiovascular disease risk assessment and prevention: current guidelines and limitations | Q38515596 | ||
| Exercise training and nutritional supplementation for physical frailty in very elderly people | Q38568481 | ||
| How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT. | Q38797551 | ||
| Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. | Q38933848 | ||
| Medication-induced diabetes during induction treatment for ALL, an early marker for future metabolic risk? | Q39221588 | ||
| Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. | Q39732493 | ||
| Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study | Q40281172 | ||
| Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study | Q40722671 | ||
| P433 | issue | 2 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 201-210 | |
| P577 | publication date | 2016-08-30 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report | |
| P478 | volume | 23 |
| Q93126220 | Assessing Cachexia Acutely after Autologous Stem Cell Transplant |
| Q39270177 | Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant. |
| Q33574136 | Late effects of blood and marrow transplantation |
| Q61446930 | Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics |
| Q50042357 | Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients |
| Q38798042 | Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care |
| Q38667959 | Long-term complications after hematopoietic cell transplantation |
| Q50527749 | Long-term systolic function in children and young adults after hematopoietic stem cell transplant. |
| Q38374821 | National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes |
| Q38808511 | National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report. |
| Q96304256 | Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach |
| Q90424728 | Prediction of cardiovascular disease among hematopoietic cell transplantation survivors |
| Q90929226 | Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study |
| Q52730156 | Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities. |
Search more.